Rieckmann K H, Cabrera E J, Campbell G H, Jost R C, Miranda R, O'Leary T R
Bull World Health Organ. 1979;57 Suppl 1(Suppl):139-51.
Evaluation of the efficacy of 3 nonviable blood-stage antigens-schizont Ag, merozoite Ag, and "French press" Ag-of Plasmodium knowlesi, emulsified in Freund's complete adjuvant (FCA), was carried out in a study involving 32 rhesus monkeys. After 2 immunizations, administered 6 weeks apart, monkeys were challenged with a variant of P. knowlesi different from that used for immunization. All 8 control monkeys that received either PBS or FCA developed a severe parasitaemia and died of the infection within 12 days after parasite challenge. In the group that received the freeze-thawed schizont Ag, 5 of the 8 monkeys died at the same time as the controls, 1 died a day later, and 2 survived the infection (maximum parasitaemia: 0.7%; 3.2%). In the freeze-thawed merozoite Ag group, 1 monkey died at the same time as the controls, 5 monkeys died between 14 and 17 days after challenge, and 2 monkeys survived the infection (maximum parasitaemia: <0.01%; 2.7%). In the lyophilized French press Ag group, 2 monkeys died at the same time as the controls, 2 died between 12 and 15 days after challenge, and 4 survived the infection (maximum parasitaemia: 1.2%; 0.4%; 0.9%; 0.07%).Immunized monkeys failed to gain weight during the period of immunization and abscess formation at injection sites was comparable in monkeys of the 3 Ag groups. Reticulocytosis and anaemia developed in all monkeys that survived longer than 12 days after challenge, even in monkeys with very low-grade levels of parasitaemia.Various tests were performed to assess humoral or cell-mediated immune responses during the period of immunization and after challenge. No clear-cut relationship could be established between the results of any of these tests and the survival of immunized monkeys after parasite challenge. Some of the results, however, suggest that there might be some relationship between cell-mediated responses and the survival of immunized monkeys beyond the survival time of control monkeys.
在一项涉及32只恒河猴的研究中,评估了诺氏疟原虫的3种无活性血液期抗原(裂殖体抗原、裂殖子抗原和“法国压榨”抗原)在弗氏完全佐剂(FCA)中乳化后的效力。在间隔6周进行2次免疫后,用与免疫所用不同的诺氏疟原虫变体对猴子进行攻击。所有8只接受PBS或FCA的对照猴子都出现了严重的寄生虫血症,并在寄生虫攻击后12天内死于感染。在接受冻融裂殖体抗原的组中,8只猴子中有5只与对照组同时死亡,1只在一天后死亡,2只在感染中存活(最大寄生虫血症:0.7%;3.2%)。在冻融裂殖子抗原组中,1只猴子与对照组同时死亡,5只猴子在攻击后14至17天死亡,2只猴子在感染中存活(最大寄生虫血症:<0.01%;2.7%)。在冻干法国压榨抗原组中,2只猴子与对照组同时死亡,2只在攻击后12至15天死亡,4只在感染中存活(最大寄生虫血症:1.2%;0.4%;0.9%;0.07%)。免疫猴子在免疫期间体重未增加,3个抗原组猴子注射部位的脓肿形成情况相当。所有在攻击后存活超过12天的猴子都出现了网织红细胞增多和贫血,即使是寄生虫血症水平很低的猴子也是如此。在免疫期间和攻击后进行了各种测试以评估体液或细胞介导的免疫反应。在这些测试的任何结果与免疫猴子在寄生虫攻击后的存活之间都无法建立明确的关系。然而,一些结果表明,细胞介导反应与免疫猴子在超过对照猴子存活时间后的存活之间可能存在某种关系。